Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0041 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0012 | 0 | 0.5 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0012 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0041 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 1 | 0.5 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0041 | 1 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0012 | 0 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0012 | 0 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0041 | 1 | 1 |
Onchocerca volvulus | 0.0012 | 0 | 0.5 | |
Entamoeba histolytica | hypothetical protein | 0.0041 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0041 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0 % | Inhibition of human RAF proto-oncogene serine/threonine-protein kinase at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human cAMP-dependent protein kinase (PKA) | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Rho-dependent protein kinase-II at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of rat Calcium/calmodulin-dependent protein kinase type II at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human c-Jun N-terminal kinase-1 alpha1 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human c-Jun N-terminal kinase-2 alpha2 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of rat c-Jun N-terminal kinase-3 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Mitogen-activated protein kinase 1 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Mitogen-activated protein kinase 2 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human RAF proto-oncogene serine/threonine-protein kinase at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Mitogen activated protein kinase kinase 1 (MEK1) at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human cAMP-dependent protein kinase (PKA) | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Rho-dependent protein kinase-II at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of rat Calcium/calmodulin-dependent protein kinase type II at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human c-Jun N-terminal kinase-1 alpha1 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human c-Jun N-terminal kinase-2 alpha2 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of rat c-Jun N-terminal kinase-3 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Mitogen-activated protein kinase 1 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 0 % | Inhibition of human Mitogen-activated protein kinase 2 at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 1 % | Inhibition of human Protein kinase B alpha at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 1 % | Inhibition of human Protein kinase B alpha at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 5 % | Inhibition of human Protein kinase C alpha | ChEMBL. | 15689155 |
Inhibition (binding) | = 5 % | Inhibition of human Protein kinase C alpha | ChEMBL. | 15689155 |
Inhibition (binding) | = 19 % | Inhibition of human Glycogen synthase kinase-3 beta at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 19 % | Inhibition of human Glycogen synthase kinase-3 beta at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 23 % | Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 23 % | Inhibition of human lymphocyte protein tyrosine kinase Lck at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 23 % | Inhibition of human stress-activated protein kinase-2 alpha (p38 MAP-kinase) at 30 uM | ChEMBL. | 15689155 |
Inhibition (binding) | = 23 % | Inhibition of human lymphocyte protein tyrosine kinase Lck at 30 uM | ChEMBL. | 15689155 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.